Home » Trials » SLCTR/2021/035


LEAP-CP ( Learning through Everyday Activities with the Parents of Children with Cerebral Palsy)

-

SLCTR Registration Number

SLCTR/2021/035


Date of Registration

11 Dec 2021

The date of last modification

Dec 11, 2021



Application Summary


Scientific Title of Trial

LEAP-CP ( Learning through Everyday Activities with the Parents of Children with Cerebral Palsy)


Public Title of Trial

The motor, social emotional and cognitive outcomes of infant at risk of neuromotor impairment disability, receiving Learning through Everyday Activities with the Parents of Children with Cerebral Palsy (LEAP-CP) programme and standard care: A randomized control trial


Disease or Health Condition(s) Studied

Cerebral Palsy


Scientific Acronym

LEAP-CP


Public Acronym

LEAP-CP study


Brief title

Early Detection, Surveillance, and Home-based early intervention for families with infants at risk of neuro-motor disabilities: implementation of evidence based guidelines into clinical care


Universal Trial Number

U1111-1271-0146


Any other number(s) assigned to the trial and issuing authority

P/55/09/2020


Trial Details


What is the research question being addressed?

How effective is a programme on early detection, surveillance, and home-based early intervention on the motor, social emotional and cognitive outcomes of infant at risk of neuromotor impairment disability compared to standard therapy?


Type of study

Interventional


Study design

Allocation

Randomized controlled trial


Masking

Double blinded : Participants, Investigators, Data analysts, Outcome assessors


Control

Standard therapy/practice


Assignment

Parallel


Purpose

Treatment


Study Phase

Not Applicable


Intervention(s) planned

Study setting: 1. Cerebral Palsy Lanka Foundation (CPLF), Sri Lanka, 2. Ayati National Center for Children with Disabilities. Method of randomization: Cluster-randomized using central concealed random allocation to receive either the LEAP-CP (CPLF) or care as usual (CAU). Participant and researchers assessing the outcomes and analyzing the data will be masked to group allocation. Details of the intervention: A multi-domain best practice intervention consisting of responsive parenting, infant goal-directed therapeutic learning games, and caregiver educational modules, based on efficacy shown in systematic reviews and Early Intervention trials (Learning through Everyday Activities with Parents of children with CP).Goal-directed skill training includes motivating infant-generated activities practiced to optimize learning; using principles of structure, repetition, and variation. Functional motor skills, such as reach/ grasp and attaining anti-gravity postures, will be coached, and parents given visual supports (photo/ video) for ongoing practice through the week. Intervention will be provided from 3-6 months for 30 weeks. Public Health Midwives and health professionals visit the families’ minimum of 6 visits per year to follow up on growth and development.


Inclusion criteria

Infants aged 3 months to <6 months identified as at high-risk of CP: • Extremely preterm (gestational age <28 weeks) • Extremely low birthweight (birth weight <1000 g) • Neonatal encephalopathy • Neurological risk factors (e.g. congenital disabilities, seizures, stroke) • General Movements “Absent fidgety” score + abnormal brain MRI/CUS indicating cerebral palsy; • General Movements “Absent fidgety” score + Hammersmith Infant Neurological Evaluation (HINE) score <57 at 12-weeks / <59 26-weeks of age; • Abnormal brain MRI/CUS indicating cerebral palsy + Hammersmith Infant Neurological Evaluation score <57 at 3 months of age/ <59 at 6 months of age. (infants with evidence of unilateral injury and clinical asymmetry indicating hemiplegia, HINE scores > 57 will be accepted as per literature).


Exclusion criteria

• Infants with lethal abnormalities • Infants with congenital conditions not associated with cerebral palsy (e.g. Down’s Syndrome) Infants with complex medical conditions requiring acute medical care



Primary outcome(s)

1.

The mean score differences in Peabody Developmental Motor Scales, edition 2 (PDMS-2). The assessment is composed of six subtests that measure interrelated motor abilities that develop early in life.

[

Pre-intervention (T0) Postintervention T1=baseline age + 30 weeks T2 = 18 months corrected age

]
2.

The mean score differences in Toddler Social Emotional Assessment (ITSEA). The tool measures multiple dimensions of social-emotional problems and competencies.

[

Pre-intervention (T0) Postintervention T1=baseline age + 30 weeks T2 = 18 months corrected age

]
3.

The primary caregiver outcome will be assessed through the Depression, Anxiety, Stress Scale – Short Form (DASS). DASS is a 42-item self report instrument designed to measure the three related negative emotional states of depression, anxiety and tension/stress.

[

Pre-intervention (T0) Postintervention T1=baseline age + 30 weeks T2 = 18 months corrected age

]

Secondary outcome(s)

1.

Mean score difference in Emotional Availability Scales (EAS), Emotional Availability-Self Report (EA-SR) and the Infant Toddler Quality of Life Questionnaire TM (ITQOL-SF47). These tools will assess behavioral and emotional problems of the study participants.

[

Pre-intervention (T0) Postintervention T1=baseline age + 30 weeks T2 = 18 months corrected age

]
2.

Mean score differences in the following tools which assesses functional outcomes of the participants: Canadian Occupational Performance Measure (COPM), the Pediatric Evaluation of Disability Inventory – Computer Adaptive Test (PEDI-CAT), the Bayley Scales of Infant Development III (BSID-III) and the Preverbal Visual Assessment (PreVIAS).

[

Pre-intervention (T0) Postintervention T1=baseline age + 30 weeks T2 = 18 months corrected age

]

Target number/sample size

86 participants (43 in each arm)


Countries of recruitment

Australia, Georgia, Sri Lanka


Anticipated start date

2022-01-15


Anticipated end date

2024-01-15


Date of first enrollment


Date of study completion


Recruitment status

Pending


Funding source

European Commission Multi-beneficiary Model Project GA 848201 as part of the H2020 programme with the acronym BORNTOGETTHERE (Grant number 848201)


Regulatory approvals



State of Ethics Review Approval


Status

Approved


Date of Approval

2021-09-14


Approval number

P/55/09/2020


Details of Ethics Review Committee

Name: Ethics Review Committee
Institutional Address:Faculty of Medicine, University of Kelaniya, Ragama, Sri Lanka
Telephone:0112961267
Email: erckelaniya@gmail.com

Contact & Sponsor Information


Contact person for Scientific Queries/Principal Investigator

Gopi Kitnasamy
Head of Rehabilitation Services
MJF Charitable Foundation 111 Negombo Road Peliyagoda
+94777554328
+94714342247

gopi291975@yahoo.com

Contact Person for Public Queries

Prof. Samanmali Sumanasena
Professor in Paediatric Disabilities
Department of Disability Studies Faculty of Medicine University of Kelaniya
+94112958251
+94777256768

samanmalis@yahoo.com


Primary study sponsor/organization







Secondary study sponsor (If any)







Trial Completion details


Do the investigators plan to share identified individual clinical trial participant-level data (IPD)?

No


IPD sharing plan description


Study protocol available

No


Protocol version and date

Not Available


Protocol URL

Not Available


Results summary available

No


Date of posting results


Date of study completion


Final sample size


Date of first publication


Link to results


Brief summary of results